Dr. Jonathan Louw

Dr. Louw brings nearly 30 years of general management and board experience across developed and emerging markets in private equity, healthcare and FMCG. He has led a business career focused on results but also on mission-driven organizations. His experience in the healthcare and pharma sectors has enabled him to make significant, even life-saving contributions in South Africa and beyond his home country. He has led businesses through transformational changes. He has been successful leading organizations in highly regulated environments while maintaining strong stakeholder relationships.

‍

Dr. Jonathan Louw joined Honoris United Universities from the South African National Blood Service (SANBS), where he served as CEO of the organisation across 185 sites and 2,700 staff. During his three-year tenure at SANBS, Dr. Louw oversaw the entire value chain of blood donation, testing and logistics through transfusion to patients across South Africa and succeeded in driving revenue growth of 17%. Additionally, he spearheaded innovation through the initiation of the organization’s first ever drone project, which transports life-saving blood products to patients in rural areas while also implementing convalescent plasma trials for the treatment of COVID-19. 

‍

Previously, he served in various leadership roles in private equity, across healthcare and pharmaceuticals, and was the CEO of JSE listed Adcock Ingram for many years.

Dr. Louw began his career in medicine in 1993 as a practicing doctor following the completion of his studies for an MB. ChB from the University of Cape Town, where he also holds an MBA.

‍